Article Details

Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma

Retrieved on: 2024-06-18 23:09:12

Tags for this article:

Click the tags to see associated articles and topics

Penpulimab, an anti-PD-1 antibody, for heavily pretreated metastatic nasopharyngeal carcinoma. View article details on hiswai:

Excerpt

... monoclonal antibodies for R/M NPC.3,4,5,6,7,8,9,10,11,12 However, these ICIs attained an objective response rate (ORR) of 20.5% (toripalimab and ...

Article found on: www.nature.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo